Nephros annual free cash flow
2010
2012
2013
2015
2016
2019
2020
2021
2022
2023
2024
Nephros Free Cash Flow (FCF) History (NEPH)
Nephros reported −$547,000 in free cash flow for fiscal 2024, a decrease of $1.3M from the previous fiscal year, with a free cash flow margin of −3.86%.
View full Nephros company overviewNephros free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$547,000 | −$1.3M | — | −3.86% |
| 2023 | 2023-12-31 | $752,000 | $4.1M | — | +5.28% |
| 2022 | 2022-12-31 | −$3.4M | −$1.9M | — | −33.79% |
| 2021 | 2021-12-31 | −$1.5M | $5.7M | — | −14.22% |
| 2020 | 2020-12-31 | −$7.1M | −$4.9M | — | −83.42% |
| 2019 | 2019-12-31 | −$2.3M | −$133,000 | — | −22.16% |
| 2016 | 2016-12-31 | −$2.2M | $1.7M | — | −92.97% |
| 2015 | 2015-12-31 | −$3.8M | −$245,000 | — | −196.91% |
| 2013 | 2013-12-31 | −$3.6M | −$2.0M | — | −205.92% |
| 2012 | 2012-12-31 | −$1.6M | −$233,000 | — | −86.05% |
| 2010 | 2010-12-31 | −$1.3M | — | — | −45.00% |
Nephros quarterly free cash flow
Q3.12
Q1.16
Q2.16
Q3.16
Q4.16
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | −$623,000 | $1.2M | — | −17.71% |
| Q4 2022 | 2022-12-31 | −$195,000 | $140,000 | — | −7.63% |
| Q3 2022 | 2022-09-30 | −$170,000 | $753,000 | — | −7.06% |
| Q2 2022 | 2022-06-30 | −$1.2M | −$1.1M | — | −41.23% |
| Q1 2022 | 2022-03-31 | −$1.8M | −$1.8M | — | −84.81% |
| Q4 2021 | 2021-12-31 | −$335,000 | $1.5M | — | −12.70% |
| Q3 2021 | 2021-09-30 | −$923,000 | −$395,000 | — | −35.80% |
| Q2 2021 | 2021-06-30 | −$117,000 | $678,000 | — | −5.16% |
| Q1 2021 | 2021-03-31 | −$78,000 | $208,000 | — | −2.85% |
| Q3 2020 | 2020-09-30 | −$1.8M | −$1.3M | — | −86.28% |
| Q4 2016 | 2016-12-31 | −$528,000 | $189,000 | — | −70.78% |
| Q3 2016 | 2016-09-30 | −$795,000 | — | — | −167.37% |
| Q2 2016 | 2016-06-30 | −$286,000 | — | — | −56.19% |
| Q1 2016 | 2016-03-31 | −$548,000 | — | — | −92.88% |
| Q3 2012 | 2012-09-30 | −$717,000 | — | — | −118.71% |
Nephros free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$2.3M to −$547,000, a net increase of $1.7M. Nephros's latest reported quarter, Q3 2024, generated −$623,000 in free cash flow, an increase of $1.2M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Nephros filings at SEC.gov ↗